Technologie de la santé
Sociétés Américaines engagées dans un secteur: technologie de la santé
Ces Sociétés Américaines opèrent dans le même secteur, technologie de la santé. Chacune d'entre elles comprend des statistiques clés telles que le cours de l'action, la variation quotidienne et le volume de transactions pour vous aider à prendre des décisions de trading plus éclairées. Que vous suiviez des géants du secteur tels que Eli Lilly and Company ou que vous observiez des sociétés à fort volume de transactions comme Jupiter Neurosciences, Inc., cette liste vous offre des informations précieuses pour toute stratégie de trading. Filtrez et comparez les entreprises et restez au fait des tendances du marché en toute simplicité.
Symbole | Capitalisation boursière | Prix | Chg % | Vol | Vol Rel | P/E | BPA dil TTM | Croissance dil du BPA YoY TTM | Rendement du Dividende % TTM | Note des analystes |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 1,11 T USD | 1 175,41 USD | +2,49% | 2,08 M | 0,83 | 42,31 | 27,78 USD | +130,14% | 0,55% | Buy |
 JNJJohnson & Johnson | 603,27 B USD | 250,61 USD | +0,72% | 7,12 M | 0,86 | 29,05 | 8,63 USD | −7,72% | 2,10% | Buy |
 ABBVAbbVie, Inc. | 452,48 B USD | 256,10 USD | +1,07% | 4,27 M | 0,70 | 126,31 | 2,03 USD | −13,55% | 2,65% | Buy |
 MRKMerck & Co., Inc. | 311,84 B USD | 126,26 USD | +1,50% | 7,24 M | 0,79 | 35,53 | 3,55 USD | −48,27% | 2,63% | Buy |
 NVSNovartis AG Sponsored ADRDR | 282,15 B USD | 153,87 USD | +2,88% | 2,65 M | 1,54 | 21,93 | 7,02 USD | +9,74% | 2,02% | Neutre |
 AZNAstraZeneca PLC | 262,63 B USD | 169,34 USD | +2,93% | 1,99 M | 0,60 | 25,81 | 6,56 USD | +29,77% | 1,87% | Buy |
 NVONovo Nordisk A/S Sponsored ADR Class BDR | 223,31 B USD | 49,38 USD | −0,46% | 5,7 M | 0,68 | 11,59 | 4,26 USD | +26,38% | 2,39% | Buy |
 AMGNAmgen Inc. | 197,66 B USD | 366,24 USD | +0,57% | 2,77 M | 1,38 | 25,47 | 14,38 USD | +31,26% | 2,64% | Buy |
 TMOThermo Fisher Scientific Inc. | 194,53 B USD | 523,46 USD | −0,53% | 3,5 M | 2,14 | 28,78 | 18,19 USD | +6,74% | 0,33% | Buy |
 ABTAbbott Laboratories | 173,61 B USD | 99,67 USD | −1,96% | 10,31 M | 0,72 | 32,22 | 3,09 USD | −61,31% | 2,47% | Buy |
 GILDGilead Sciences, Inc. | 161,75 B USD | 130,28 USD | −2,20% | 8,23 M | 1,30 | 17,73 | 7,35 USD | +54,54% | 2,36% | Strong Buy |
 PFEPfizer Inc. | 142,14 B USD | 24,94 USD | +0,77% | 26,46 M | 0,66 | 19,12 | 1,30 USD | −5,38% | 6,84% | Neutre |
 DHRDanaher Corporation | 126,7 B USD | 179,01 USD | −10,99% | 27,86 M | 7,12 | 34,60 | 5,17 USD | +0,32% | 0,70% | Strong Buy |
 BMYBristol-Myers Squibb Company | 124,42 B USD | 60,93 USD | +1,28% | 7,74 M | 0,72 | 17,10 | 3,56 USD | +33,76% | 4,13% | Buy |
 ISRGIntuitive Surgical, Inc. | 123,98 B USD | 350,06 USD | −0,88% | 4,92 M | 1,16 | 40,12 | 8,73 USD | +21,76% | 0,00% | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 122,33 B USD | 482,00 USD | +0,31% | 1,11 M | 0,71 | 28,57 | 16,87 USD | — | 0,00% | Buy |
 SYKStryker Corporation | 120,6 B USD | 314,58 USD | −1,43% | 1,33 M | 0,53 | 36,44 | 8,63 USD | +16,51% | 1,05% | Buy |
 SNYSanofi SA Sponsored ADRDR | 106,7 B USD | 43,75 USD | −0,52% | 2,19 M | 0,69 | 18,32 | 2,39 USD | −0,28% | 3,99% | Buy |
 MDTMedtronic Plc | 105,41 B USD | 82,35 USD | −1,13% | 4,37 M | 0,58 | 22,10 | 3,73 USD | +3,00% | 3,41% | Buy |
 GSKGSK plc Sponsored ADRDR | 103,43 B USD | 50,78 USD | +1,48% | 3,9 M | 0,97 | 13,28 | 3,82 USD | +98,54% | 3,35% | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 70,79 B USD | 675,19 USD | +0,45% | 528,14 K | 0,80 | 16,45 | 41,04 USD | +4,47% | 0,54% | Buy |
 BSXBoston Scientific Corporation | 64,2 B USD | 43,19 USD | −1,33% | 23,38 M | 1,60 | 18,11 | 2,38 USD | +74,74% | 0,00% | Strong Buy |
 TAKTakeda Pharmaceutical Co. Ltd. Sponsored ADRDR | 53,84 B USD | 17,23 USD | +1,06% | 4,81 M | 1,31 | — | −0,29 USD | −232,57% | 3,70% | Buy |
 ARGXargenx SE Sponsored ADRDR | 53,83 B USD | 874,74 USD | +3,37% | 256,57 K | 0,92 | 44,67 | 19,58 USD | +53,53% | 0,00% | Strong Buy |
 MDLNMedline, Inc. Class A | 51,35 B USD | 39,09 USD | +0,54% | 4,92 M | 0,89 | 32,69 | 1,20 USD | −22,07% | 0,00% | Buy |
 EWEdwards Lifesciences Corporation | 48,68 B USD | 84,55 USD | −0,53% | 5,55 M | 1,14 | 45,94 | 1,84 USD | +22,98% | 0,00% | Buy |
 HLNHaleon PLC Sponsored ADRDR | 44,3 B USD | 9,92 USD | −1,20% | 10,68 M | 1,50 | 20,37 | 0,49 USD | +21,29% | 1,81% | Buy |
 IDXXIDEXX Laboratories, Inc. | 43,58 B USD | 552,46 USD | −2,01% | 409,29 K | 0,62 | 40,65 | 13,59 USD | +25,58% | 0,00% | Buy |
 BDXBecton, Dickinson and Company | 42,39 B USD | 153,84 USD | −0,41% | 1,27 M | 0,72 | 39,01 | 3,94 USD | −24,74% | 2,62% | Buy |
 RVMDRevolution Medicines, Inc. | 38,97 B USD | 183,29 USD | +1,61% | 2,3 M | 1,19 | — | −7,07 USD | −76,93% | 0,00% | Strong Buy |
 NTRANatera, Inc. | 38,26 B USD | 267,18 USD | +1,73% | 990,26 K | 0,81 | — | −1,64 USD | −11,94% | 0,00% | Strong Buy |
 TEVATeva Pharmaceutical Industries Limited Sponsored ADRDR | 37,57 B USD | 31,35 USD | +1,13% | 4,85 M | 0,97 | 23,30 | 1,35 USD | — | 0,00% | Strong Buy |
 AAgilent Technologies, Inc. | 37,52 B USD | 132,86 USD | +2,00% | 2,37 M | 1,03 | 26,68 | 4,98 USD | +22,80% | 0,74% | Buy |
 ALNYAlnylam Pharmaceuticals, Inc | 36,23 B USD | 271,37 USD | −0,48% | 948,26 K | 0,49 | 64,48 | 4,21 USD | — | 0,00% | Buy |
 WATWaters Corporation | 36,09 B USD | 367,55 USD | +2,80% | 1,15 M | 1,74 | 46,79 | 7,86 USD | −28,76% | 0,00% | Buy |
 ONCBeOne Medicines Ltd. Sponsored ADRDR | 35,34 B USD | 318,69 USD | +2,61% | 536,2 K | 1,37 | 71,11 | 4,48 USD | — | 0,00% | Strong Buy |
 ALCAlcon AG | 33,65 B USD | 67,35 USD | −3,84% | 2,19 M | 0,91 | 40,50 | 1,66 USD | −26,23% | 0,49% | Strong Buy |
 IQVIQVIA Holdings Inc | 33,65 B USD | 201,62 USD | −1,12% | 1 M | 0,92 | 24,99 | 8,07 USD | +9,95% | 0,00% | Buy |
 RPRXRoyalty Pharma Plc Class A | 33,64 B USD | 58,42 USD | +1,96% | 3,69 M | 1,30 | 30,60 | 1,91 USD | −22,13% | 1,55% | Strong Buy |
 ZTSZoetis, Inc. Class A | 31,59 B USD | 75,35 USD | −1,12% | 4,83 M | 0,84 | 12,48 | 6,04 USD | +8,39% | 2,68% | Buy |
 BIIBBiogen Inc. | 29,99 B USD | 203,16 USD | +1,61% | 652,83 K | 0,36 | 21,80 | 9,32 USD | −7,98% | 0,00% | Buy |
 ILMNIllumina, Inc. | 29,13 B USD | 192,53 USD | +4,25% | 1,36 M | 0,81 | 34,94 | 5,51 USD | — | 0,00% | Buy |
 DXCMDexCom, Inc. | 28,84 B USD | 74,75 USD | −1,24% | 3,85 M | 0,85 | 31,97 | 2,34 USD | +75,52% | 0,00% | Strong Buy |
 RMDResMed Inc. | 28,4 B USD | 195,80 USD | −1,41% | 1,11 M | 0,76 | 18,88 | 10,37 USD | +16,47% | 1,18% | Buy |
 GEHCGE Healthcare Technologies Inc. | 28,22 B USD | 62,04 USD | −1,26% | 2,96 M | 0,54 | 14,85 | 4,18 USD | −12,17% | 0,21% | Buy |
 MTDMettler-Toledo International Inc. | 26,23 B USD | 1 298,17 USD | +1,92% | 170,48 K | 1,23 | 30,45 | 42,64 USD | +6,35% | 0,00% | Buy |
 WSTWest Pharmaceutical Services, Inc. | 25,38 B USD | 359,24 USD | +1,96% | 724,73 K | 1,13 | 48,02 | 7,48 USD | +17,47% | 0,24% | Strong Buy |
 ROIVRoivant Sciences Ltd. | 25,15 B USD | 34,96 USD | +2,67% | 4,73 M | 1,00 | — | −0,50 USD | −102,57% | 0,00% | Strong Buy |
 MRNAModerna, Inc. | 23,67 B USD | 59,66 USD | +0,29% | 4,12 M | 0,67 | — | −8,15 USD | +6,61% | 0,00% | Neutre |
 INSMInsmed Incorporated | 23,54 B USD | 108,62 USD | +1,50% | 2,45 M | 1,01 | — | −5,74 USD | +3,42% | 0,00% | Strong Buy |
 INCYIncyte Corporation | 23,45 B USD | 117,39 USD | +1,50% | 1,91 M | 1,21 | 16,60 | 7,07 USD | +2 088,03% | 0,00% | Buy |
 BNTXBioNTech SE Sponsored ADRDR | 23,13 B USD | 92,33 USD | +0,18% | 676,59 K | 0,87 | — | −5,87 USD | −70,89% | 0,00% | Buy |
 UTHRUnited Therapeutics Corporation | 22,74 B USD | 535,83 USD | +1,23% | 463,78 K | 1,27 | 19,78 | 27,09 USD | +8,13% | 0,00% | Buy |
 VTRSViatris, Inc. | 20,65 B USD | 17,59 USD | +3,53% | 8,54 M | 1,00 | — | −0,26 USD | +91,85% | 2,77% | Buy |
 STESTERIS plc | 20,64 B USD | 211,75 USD | −1,27% | 571,81 K | 0,79 | 26,69 | 7,93 USD | +26,66% | 1,14% | Buy |
 GHGuardant Health, Inc. | 20,19 B USD | 152,29 USD | +2,85% | 1,49 M | 0,63 | — | −3,40 USD | −0,63% | 0,00% | Strong Buy |
 NBIXNeurocrine Biosciences, Inc. | 18 B USD | 179,05 USD | +3,50% | 1,31 M | 1,22 | 27,53 | 6,50 USD | +120,55% | 0,00% | Strong Buy |
 ZBHZimmer Biomet Holdings, Inc. | 17,2 B USD | 88,92 USD | −0,89% | 1,78 M | 0,78 | 23,09 | 3,85 USD | −14,65% | 1,02% | Neutre |
 GMABGenmab A/S Sponsored ADRDR | 17,04 B USD | 28,37 USD | +1,63% | 871,69 K | 0,34 | 21,39 | 1,33 USD | −24,78% | 0,00% | Strong Buy |
 BBIOBridgeBio Pharma, Inc. | 16,16 B USD | 82,45 USD | +2,09% | 1,35 M | 0,29 | — | −3,75 USD | −6,09% | 0,00% | Strong Buy |
 JAZZJazz Pharmaceuticals Public Limited Company | 15,97 B USD | 254,22 USD | +4,42% | 809,88 K | 1,15 | — | −0,02 USD | −100,25% | 0,00% | Buy |
 ASNDAscendis Pharma A/S | 15,92 B USD | 255,20 USD | +1,37% | 545,93 K | 0,97 | 28,76 | 8,87 USD | — | 0,00% | Strong Buy |
 EXELExelixis, Inc. | 14,11 B USD | 56,12 USD | +1,06% | 1,82 M | 0,75 | 18,60 | 3,02 USD | +36,88% | 0,00% | Buy |
 COOCooper Companies, Inc. | 13,85 B USD | 71,01 USD | −0,81% | 2,24 M | 1,05 | 59,97 | 1,18 USD | −42,57% | 0,00% | Buy |
 SNNSmith & Nephew plc Sponsored ADRDR | 13,06 B USD | 30,21 USD | −0,72% | 1,13 M | 0,62 | 21,05 | 1,44 USD | +52,50% | 2,39% | Buy |
 ELANElanco Animal Health, Inc. | 12,73 B USD | 25,48 USD | +1,35% | 5,52 M | 1,39 | — | −0,49 USD | −165,27% | 0,00% | Strong Buy |
 ALGNAlign Technology, Inc. | 12,71 B USD | 177,50 USD | +1,40% | 683,05 K | 0,81 | 29,75 | 5,97 USD | +8,58% | 0,00% | Buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 12,61 B USD | 546,79 USD | +2,07% | 222,27 K | 0,69 | — | −12,80 USD | +29,06% | 0,00% | Strong Buy |
 PENPenumbra, Inc. | 12,48 B USD | 317,39 USD | −0,19% | 220,11 K | 0,59 | 73,03 | 4,35 USD | +307,61% | 0,00% | Neutre |
 RVTYRevvity, Inc. | 12,33 B USD | 110,52 USD | +3,83% | 1,61 M | 1,44 | 52,39 | 2,11 USD | −16,59% | 0,25% | Buy |
 AXSMAxsome Therapeutics, Inc. | 12,19 B USD | 236,95 USD | +6,91% | 946,75 K | 1,23 | — | −3,74 USD | +35,18% | 0,00% | Strong Buy |
 ABVXAbivax SA Sponsored ADRDR | 11,9 B USD | 134,09 USD | +1,97% | 751,76 K | 0,66 | — | −5,25 USD | −41,66% | 0,00% | Strong Buy |
 BAXBaxter International Inc. | 11,47 B USD | 22,21 USD | +0,63% | 3,96 M | 0,69 | — | −1,95 USD | −77,71% | 0,86% | Neutre |
 BMRNBioMarin Pharmaceutical Inc. | 11,44 B USD | 59,21 USD | +0,17% | 1,62 M | 1,19 | 43,20 | 1,37 USD | −49,15% | 0,00% | Buy |
 SMMTSummit Therapeutics Inc | 11,36 B USD | 14,63 USD | +8,37% | 3,92 M | 1,36 | — | −1,60 USD | −384,68% | 0,00% | Buy |
 PODDInsulet Corporation | 11,34 B USD | 163,72 USD | −2,18% | 1,15 M | 0,87 | 38,11 | 4,30 USD | −22,68% | 0,00% | Strong Buy |
 TECHBio-Techne Corporation | 11,22 B USD | 71,63 USD | −0,01% | 3 M | 0,81 | 102,89 | 0,70 USD | −15,14% | 0,45% | Neutre |
 ARWRArrowhead Pharmaceuticals, Inc. | 10,5 B USD | 74,52 USD | +4,01% | 1,61 M | 0,71 | — | −2,15 USD | −55,90% | 0,00% | Strong Buy |
 RDYDr. Reddy's Laboratories Ltd. Sponsored ADRDR | 10,48 B USD | 12,56 USD | +0,24% | 1,44 M | 0,53 | 21,39 | 0,59 USD | −26,66% | 0,56% | Neutre |
 GMEDGlobus Medical Inc Class A | 10,32 B USD | 76,09 USD | +0,11% | 1,15 M | 0,56 | 17,72 | 4,29 USD | +221,17% | 0,00% | Buy |
 CORTCorcept Therapeutics Incorporated. | 10,27 B USD | 95,65 USD | +4,46% | 822,8 K | 0,66 | 273,29 | 0,35 USD | −69,62% | 0,00% | Strong Buy |
 APGEApogee Therapeutics, Inc. | 10,11 B USD | 134,20 USD | +0,04% | 428,06 K | 0,32 | — | −4,33 USD | −22,17% | 0,00% | Neutre |
 CYTKCytokinetics, Incorporated | 10,09 B USD | 81,11 USD | +2,53% | 1,21 M | 0,70 | — | −6,84 USD | −28,90% | 0,00% | Strong Buy |
 KRYSKrystal Biotech, Inc. | 10 B USD | 339,06 USD | −0,05% | 445,49 K | 1,21 | 45,32 | 7,48 USD | +80,17% | 0,00% | Strong Buy |
 KYMRKymera Therapeutics, Inc. | 9,33 B USD | 113,37 USD | +2,08% | 565,37 K | 0,87 | — | −3,57 USD | −15,21% | 0,00% | Strong Buy |
 HALOHalozyme Therapeutics, Inc. | 9,32 B USD | 78,60 USD | +1,96% | 1,27 M | 0,72 | 28,27 | 2,78 USD | −26,23% | 0,00% | Buy |
 BRKRBruker Corporation | 9,2 B USD | 60,43 USD | +7,58% | 2,75 M | 1,56 | — | −0,24 USD | −145,78% | 0,34% | Buy |
 GKOSGlaukos Corp | 8,99 B USD | 153,09 USD | −1,52% | 476,79 K | 0,76 | — | −3,29 USD | −42,48% | 0,00% | Strong Buy |
 SYRESpyre Therapeutics, Inc | 8,92 B USD | 102,70 USD | +5,52% | 774,65 K | 0,59 | — | −2,36 USD | +22,31% | 0,00% | Strong Buy |
 PTGXProtagonist Therapeutics, Inc. | 8,89 B USD | 138,31 USD | +3,01% | 578,85 K | 0,66 | — | −1,80 USD | −337,12% | 0,00% | Strong Buy |
 CRNXCrinetics Pharmaceuticals Inc | 8,88 B USD | 83,90 USD | +0,04% | 2,72 M | 0,19 | — | −5,13 USD | −34,49% | 0,00% | Neutre |
 PRAXPraxis Precision Medicines, Inc. | 8,86 B USD | 317,87 USD | +4,41% | 215,59 K | 0,60 | — | −13,38 USD | −24,90% | 0,00% | Strong Buy |
 IONSIonis Pharmaceuticals, Inc. | 8,82 B USD | 53,39 USD | +0,83% | 3,03 M | 0,52 | — | −2,10 USD | +29,54% | 0,00% | Strong Buy |
 ALKSAlkermes Public Limited Company | 8,81 B USD | 52,85 USD | +2,18% | 1,18 M | 0,73 | 58,75 | 0,90 USD | −57,17% | 0,00% | Buy |
 IBRXImmunityBio Inc | 8,45 B USD | 8,07 USD | +7,67% | 8,61 M | 0,92 | — | −0,85 USD | −46,05% | 0,00% | Strong Buy |
 PCVXVaxcyte, Inc. | 8,38 B USD | 58,04 USD | +4,58% | 852,73 K | 0,81 | — | −6,97 USD | −71,33% | 0,00% | Strong Buy |
 QGENQIAGEN NV | 8,35 B USD | 40,53 USD | +0,12% | 2,07 M | 0,55 | 20,94 | 1,94 USD | +340,51% | 0,63% | Buy |
 TGTXTG Therapeutics, Inc. | 8,26 B USD | 53,95 USD | −0,02% | 1,48 M | 0,78 | 18,80 | 2,87 USD | +1 076,02% | 0,00% | Buy |
 BIOBio-Rad Laboratories, Inc. Class A | 8,12 B USD | 301,70 USD | −0,07% | 298,99 K | 1,08 | 49,66 | 6,07 USD | — | 0,00% | Neutre |
 IMVTImmunovant Inc | 8,12 B USD | 39,53 USD | −0,98% | 1,25 M | 1,20 | — | −2,77 USD | −1,22% | 0,00% | Buy |